Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Magnhild Gangsøy Kristiansen"'
Autor:
Rasmus Goll, Hege Kileng, Anders Lannergård, Soo Aleman, Magnhild Gangsøy Kristiansen, Navaneethan Palanisamy, Midori Kjellin, Johan Lennerstrand, Astrid Danielsson, Dario Akaberi, Johan Edvin Nöjd, Tore Jarl Gutteberg, Ann-Sofi Duberg
Background: The NS5A resistance-associated substitution (RAS) Y93H is found quite frequently (5–10%) at baseline in direct-acting antiviral agents (DAA) treatment-naïve genotype (GT) 3a patients when studied by the population-sequencing method (cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b576b31090b84cc37bb398ab1acbf2a
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396109
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396109
Autor:
Magnhild Gangsøy Kristiansen, Ann-Sofi Duberg, Hege Kileng, Johan Lennerstrand, Rasmus Goll, Assar Bergfors, Anders Lannergård, Lars Wesslen, Dario Akaberi, Midori Kjellin, Tore Jarl Gutteberg, Astrid Danielsson
Source at https://doi.org/10.1080/00365521.2018.1511824. Objectives: Resistance-associated substitutions (RASs) may impair treatment response to direct-acting antivirals (DAA) in hepatitis C virus (HCV) treatment. We investigated the effects of basel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4ef79b35126728c42f9e1de35b6604
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-371722
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-371722
Autor:
Lars Bernfort, Jon Florholmen, Rasmus Goll, Eyvind J. Paulssen, Leif Kyrre Berg, Tore Jarl Gutteberg, Magnhild Gangsøy Kristiansen, Odd Sverre Moen, Hege Kileng
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-9 (2017)
Source at: https://doi.org/10.1186/s12879-017-2722-0. © The Author(s). 2017 Background: Hepatitis C (HCV) infection causes an asymptomatic chronic hepatitis in most affected individuals, which often remains undetected until cirrhosis and cirrhosis-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc60f717431af497a2606bc7e6b8837
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141713
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141713
Autor:
Jon Florholmen, Maja-Lisa Løchen, Magnhild Gangsøy Kristiansen, Tore Jarl Gutteberg, Bjørn Odvar Eriksen, Liisa Mortensen
Publikováno v:
Journal of Viral Hepatitis. 18:237-244
Knowledge of the natural course and especially the total and cause-specific mortality of community-acquired chronic HCV infection is limited. The aims of our study were to determine the total and cause-specific mortality in patients infected with chr
Autor:
Anil Amin, Odd Kildahl-Andersen, Anna M Wessel-Berg, Kåre Nordgård, Liisa Mortensen, Magnhild Gangsøy Kristiansen, Per Christian Valle, Einar Husebye, Ragnar K. Breckan
Publikováno v:
Scandinavian Journal of Gastroenterology. 41:161-169
To test the ability of pre-endoscopic clinical evaluation to predict clinically relevant findings of upper gastrointestinal endoscopy.Patients (341) who had been referred to upper gastrointestinal endoscopy for further evaluation of dyspeptic symptom
Autor:
Edvard Falk, Bjørn Odvar Eriksen, Liisa Mortensen, Tore Jarl Gutteberg, Maja-Lisa Løchen, Jon Florholmen, Magnhild Gangsøy Kristiansen
Publikováno v:
Scandinavian Journal of Gastroenterology. 44:894-896
Autor:
Magnhild Gangsøy, Kristiansen, Bjørn Odvar, Eriksen, Jan Martin, Maltau, Bjórn, Holdo, Tore Jarl, Gutteberg, Liisa, Mortensen, Maja-Lisa, Løchen, Jon, Florholmen
Publikováno v:
Hepato-gastroenterology. 56(93)
No data exist for current infections of hepatitis C and hepatitis B virus in pregnant women in Northern Norway. The aim of this study was to determine the prevalences of viremic hepatitis C and hepatitis B of pregnant women in Northern Norway. A cros
Autor:
Magnhild Gangsøy, Kristiansen, Tore, Gutteberg, Leif Kyrre, Berg, Haakon, Sjursen, Liisa, Mortensen, Jon, Florholmen
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 122(20)
In 1992 a screening and medical follow-up programme of patients with hepatitis C was established in northern Norway. We report the data from the eight-year observation period.Patients with positive recombinant immunoblot assay (RIBA) confirmation tes